Work

Bioconversion of Deproteinized Cheese Whey to Metabolites by Understudied Cryptococcus-Related Yeasts: Characterization and Properties of Extracted Polysaccharides

Year: 2025
Type: article
Abstract: Microbial bioconversion of agro-industrial by-products into high-value-added metabolites such as polysaccharides or lipids serves a dual purpose: mitigating environmental pollution through waste reduction and supporting the development of novel bioproducts. In this study, a non-conventional, poorly studied Cryptococcus albidus strain was initially assessed for its ability to grow on semi-defined media containing lactose, glycerol, or glucose under three distinct nitrogen availability conditions at C/N equal to 20, 80, and 160 mol/mol in shake flask cultures. The goal was to evaluate biomass production and synthesis of valuable metabolites under these conditions. C. albidus demonstrated robust growth on all commercial carbon sources, particularly under nitrogen-rich conditions, producing more than 25.0 g/L of microbial biomass with a high intracellular polysaccharide content (>45%, w/w). Additionally, mannitol production was detected in cultures with glycerol and glucose (9.1 and 13.1 g/L, respectively), especially after nitrogen depletion. Subsequently, C. albidus and a Cutaneotrichosporon curvatus strain were batch-cultivated using pretreated secondary cheese whey (SCW) as a carbon-rich waste substrate. When cultivated on SCW, both yeast strains partially metabolized lactose and produced polysaccharide-rich biomass, dominated by β-glucans (>29% of total biomass), compounds known for their functional and bioactive properties. The cellular polysaccharides (cPS extracted from C. albidus exhibited cytotoxic effects against cancer cells, suggesting their potential use as biological response modifiers. In contrast, the cPS from C. curvatus did not affect cell viability, indicating their promise as ingredients for applications in the food, feed, pharmaceutical, or cosmetic sectors.
Source: Dairy
Language: English
Subfield: Pharmacology
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,448
OpenAlex ID: W4416458387
FWCI: 0.989
Cites:
Cited by: 2
Related to: